Literature DB >> 10094373

Cardiac troponin I and troponin T: recent players in the field of myocardial markers.

J P Chapelle1.   

Abstract

The troponin (Tn) complex consists of three subunits referred to as TnT, TnI and TnC. Myocardium contains TnT and TnI isoforms which are not present in skeletal muscles and which can be separated from the muscular isoforms by immunological techniques. Using commercially available immunoassays, clinical laboratories are able to determine cardiac TnT and TnI (cTnT and cTnI) quickly and reliably as classical cardiac markers. After acute myocardial infarction, cTnT and cTnI concentrations start to increase in serum in a rather similar way than CK-MB, but return to normal after longer periods of time (approximately one week). Because of their excellent cardiac specificity, Tn subunits appear ideally suited for the differential diagnosis of myocardial and muscular damage, for example in noncardiac surgery patients, in patients with muscular trauma or with chronic muscular diseases, or after intense physical exercise. cTnT and cTnI may also be used for detecting evidence of minor myocardial damage: therefore they have found new clinical applications, in particular risk stratification in patients with unstable angina. In spite of the possible reexpression of cTnT in human skeletal muscles, and of the lack of standardization of cTnI assays, Tn subunits are not far to meet the criteria of ideal markers for acute myocardial injury. Only an insufficient sensitivity in the first hours following the acute coronary syndroms requiries to maintain an early myocardial marker in the cardiac panel for routine laboratory testing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094373     DOI: 10.1515/CCLM.1999.002

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  3 in total

1.  Comparative study of cardiac troponin I and T measurements in a routine extra-cardiological clinical setting.

Authors:  F Pagani; G Bonetti; M Panteghini
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice.

Authors:  Jessica L Dries; Susan D Kent; Jitka A I Virag
Journal:  J Physiol       Date:  2011-01-31       Impact factor: 5.182

3.  DNA methylation regulates mouse cardiac myofibril gene expression during heart development.

Authors:  Yang Xu; Lingjuan Liu; Bo Pan; Jing Zhu; Changlong Nan; Xupei Huang; Jie Tian
Journal:  J Biomed Sci       Date:  2015-10-17       Impact factor: 8.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.